Senesco Annual Board Meeting for Shareholders

On Thursday, March 28th the Senesco Board of directors held its annual meeting in New York City. Chris and I attended the meeting. Missing from the meeting was CEO Les Browne who was ill at the time.

The meeting was conducted by Senesco Chairman Harlan Waksal, MD from whom we learned a great deal of new information on the progression of the Factor 5A therapy. We have been supporters of Dr. John Thompson's discovery of a novel, non-mutated and very old gene, for the past eight years. The Gene is called Eukaryotic Initial Translation Factor 5A1 or eIF5a. We shall simply refer to it as Factor 5A.

Written by Micheal Berry, MBA - [ Discovery Investing Web Site ]